Velagliflozin information

Velagliflozin
Clinical data
Trade names	Senvelgo
License data	US DailyMed: Velagliflozin;
Routes of; administration	By mouth
ATCvet code	QA10BK90 (WHO) ;
Legal status
Legal status	US: ℞-only;
Identifiers
	IUPAC name 2-[(4-cyclopropylphenyl)methyl]-4-[(2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]benzonitrile;
CAS Number	946525-65-1;
PubChem CID	24862817;
ChemSpider	58827717;
UNII	FV2YU8SL0P; EQE2P2T77I;
Chemical and physical data
Formula	C23H25NO5
Molar mass	395.455 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES C1CC1C2=CC=C(C=C2)CC3=C(C=CC(=C3)[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)C#N;
	InChI InChI=1S/C23H25NO5/c24-11-17-8-7-16(23-22(28)21(27)20(26)19(12-25)29-23)10-18(17)9-13-1-3-14(4-2-13)15-5-6-15/h1-4,7-8,10,15,19-23,25-28H,5-6,9,12H2/t19-,20-,21+,22-,23+/m1/s1; Key:SENUNDCNOYAWGN-ZQGJOIPISA-N; Key:UWKBFNWQMSGEPG-ZHNCTCHCSA-N;

Velagliflozin, sold under the brand name Senvelgo, is an antidiabetic medication used for the treatment of cats.^[1]^[2] Velagliflozin is a sodium-glucose cotransporter 2 (SGLT2) inhibitor.^[3] It is taken by mouth.^[1]

^ ^a ^b ^c "Senvelgo- velagliflozin solution". DailyMed. 8 November 2023. Retrieved 13 December 2023.
^ https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadFoi/14320 This article incorporates text from this source, which is in the public domain.
^ "Dear Veterinarian Letter regarding important safety conditions associated with the use of Senvelgo (velagliflozin oral solution) for improving glycemic control in certain cats with diabetes mellitus". U.S. Food and Drug Administration. 4 December 2023. Retrieved 13 December 2023. This article incorporates text from this source, which is in the public domain.

[Senvelgo_FDA_label-1] "Senvelgo- velagliflozin solution". DailyMed. 8 November 2023. Retrieved 13 December 2023.

[Senvelgo_Freedom_of_Information_Summary-2] ttps://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadFoi/14320 This article incorporates text from this source, which is in the public domain.

[FDA_Dear_Vet-3] "Dear Veterinarian Letter regarding important safety conditions associated with the use of Senvelgo (velagliflozin oral solution) for improving glycemic control in certain cats with diabetes mellitus". U.S. Food and Drug Administration. 4 December 2023. Retrieved 13 December 2023. This article incorporates text from this source, which is in the public domain.

Velagliflozin information

and 27 Related for: Velagliflozin information

Velagliflozin

Semaglutide

Retatrutide

List of veterinary drugs

Empagliflozin

Metformin

Dulaglutide

Insulin glargine

Tirzepatide

SGLT2 inhibitor

Sitagliptin

Dapagliflozin

ATC code A10

Canagliflozin

Danuglipron

Pioglitazone

Insulin aspart

NPH insulin

Biguanide

Thiazolidinedione

Linagliptin

Regular insulin

Acarbose

Insulin degludec

Boehringer Ingelheim

Sulfonylurea

Bromocriptine